US equities
|
MU
$1,074.89
▲+0.00%
INTC
$119.13
▼-0.17%
NVDA
$233.95
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
MU
$1,074.89
▲+0.00%
INTC
$119.13
▼-0.17%
NVDA
$233.95
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Calidi Biotherapeutics, Inc. Common Stock
(NY:
CLDI
)
1.080
UNCHANGED
Delayed Quote
Updated: 8:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Calidi Biotherapeutics, Inc. Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
US Stocks Likely To Open Higher: Trump's Tariff Clock Ticks, Fed Likely To Keep Rates Unchanged
↗
July 09, 2025
U.S. stock futures advanced on Wednesday after ending on a mixed note on Tuesday. Futures of major benchmark indices were trading higher.
Via
Benzinga
Topics
Economy
Government
Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
↗
July 09, 2025
Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
Via
Benzinga
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On
↗
July 09, 2025
Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovative cancer treatment developments.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 08, 2025
Via
Benzinga
InvestorNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Featured in Editorial Highlighting Breakthrough Genetic Medicine Platform
July 08, 2025
Via
Investor Brand Network
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Featured in Editorial Highlighting Breakthrough Genetic Medicine Platform
July 08, 2025
Via
Investor Brand Network
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
July 08, 2025
From
Calidi Biotherapeutics Inc.
Via
GlobeNewswire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
Via
Investor Brand Network
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:REGN),(NASDAQ:VRTX),(OTCQX:RHHBY),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Study Discovers Genetic Mutation that Makes Solid Tumors Unresponsive to Immunotherapy
July 03, 2025
Via
Investor Brand Network
BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Highlights 2025 Pipeline Progress and Strategic Focus in Shareholder Letter
June 27, 2025
Via
Investor Brand Network
Could Wheat Germ Hold the Key to Supercharging Immunotherapy? New Research Hopes to Find Out
June 24, 2025
Via
Investor Brand Network
Top movers in Monday's after hours session
↗
June 23, 2025
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Study Explains Why Most Smokers Never Get to Develop Lung Cancer
June 23, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 13, 2025
Via
Benzinga
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Taps Biotech Veteran to Lead Next Phase of Growth
June 10, 2025
Via
Investor Brand Network
Celebrity Announcements of Breast Cancer Underscore Increasing Prevalence in Younger Women
June 10, 2025
Via
Investor Brand Network
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Unveils Promising Data on CLD-401 at ASCO 2025
June 05, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 03, 2025
Via
Benzinga
Korean Researchers Develop AI to Predict Cancer Patients’ Response to Immunotherapy
June 02, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
University of Houston Gets $3M to Establish Biomarker Core for Cancer Immunotherapy
May 29, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) RTNova Shows Promise in Targeted Tumor Therapy
May 22, 2025
Via
Investor Brand Network
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names Experienced Life Science Leader as New CEO
May 19, 2025
Via
Investor Brand Network
New Multimodal AI System Boosts the Accuracy of Lung Cancer Screening
May 16, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances Redtail Virotherapy Platform and Reduces Q1 Losses
May 15, 2025
Via
Investor Brand Network
Getting a Second Opinion After Breast Cancer Diagnosis Doesn’t Delay Treatment Commencement
May 12, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Eyes Game-Changing Approach to Cancer Treatment
May 09, 2025
Via
Investor Brand Network
Study: Women with Lung Cancer Have Worse Outcomes Due to Genes Linked to Pregnancy
May 06, 2025
Via
Investor Brand Network
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Committed to Advancing Cancer Care with Innovative RTNova Platform Research
April 30, 2025
Via
Investor Brand Network
Topics
Death
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Innovative RTNova Platform Research, Exemplifies Pivotal Role of Research
April 29, 2025
Via
Investor Brand Network
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
